{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:35:22Z","timestamp":1790523322223,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 T32 HL 82547-7"],"award-info":[{"award-number":["5 T32 HL 82547-7"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1378\/chest.14-1120","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T20:17:10Z","timestamp":1409861830000},"page":"438-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":210,"title":["Racial Difference in Sarcoidosis Mortality in the United States"],"prefix":"10.1016","volume":"147","author":[{"given":"Mehdi","family":"Mirsaeidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto F.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Schraufnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1378\/chest.14-1120_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.10","article-title":"Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics","volume":"305","author":"Iannuzzi","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1378\/chest.14-1120_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccm.2006.04.002","article-title":"Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics","volume":"27","author":"Westney","year":"2006","journal-title":"Clin Chest Med"},{"issue":"2","key":"10.1378\/chest.14-1120_bib3","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.14-1120_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1378\/chest.14-1120_bib5","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/oxfordjournals.aje.a010298","article-title":"Re: \u201cGeographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators.\u201d","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1378\/chest.14-1120_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/oxfordjournals.aje.a009998","article-title":"Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators","volume":"150","author":"Kajdasz","year":"1999","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1378\/chest.14-1120_bib7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/oxfordjournals.aje.a121609","article-title":"Epidemiology of sarcoidosis in the US Navy","volume":"99","author":"Sartwell","year":"1974","journal-title":"Am J Epidemiol"},{"issue":"10 pt 1","key":"10.1378\/chest.14-1120_bib8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.14-1120_bib9","first-page":"361","article-title":"Cutaneous manifestations of sarcoidosis in blacks","volume":"32","author":"Minus","year":"1983","journal-title":"Cutis"},{"issue":"3","key":"10.1378\/chest.14-1120_bib10","first-page":"204","article-title":"ACCESS Research Group Two year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"2","key":"10.1378\/chest.14-1120_bib11","first-page":"124","article-title":"Hospitalization for patients with sarcoidosis: 1979-2000","volume":"23","author":"Foreman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"11","key":"10.1378\/chest.14-1120_bib12","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","article-title":"Sarcoidosis-related mortality in the United States from 1988 to 2007","volume":"183","author":"Swigris","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.14-1120_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2466-12-19","article-title":"Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study","volume":"12","author":"Gerke","year":"2012","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1378\/chest.14-1120_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9343(97)89518-6","article-title":"Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data","volume":"100","author":"Gideon","year":"1996","journal-title":"Am J Med"},{"issue":"3","key":"10.1378\/chest.14-1120_bib16","doi-asserted-by":"crossref","first-page":"e91879","DOI":"10.1371\/journal.pone.0091879","article-title":"Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study","volume":"9","author":"Mirsaeidi","year":"2014","journal-title":"PLoS One"},{"issue":"5 pt 2","key":"10.1378\/chest.14-1120_bib18","first-page":"116","article-title":"Mortality from sarcoidosis in the United States","volume":"84","author":"Moriyama","year":"1961","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1378\/chest.14-1120_bib19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1183\/09031936.01.17408330","article-title":"Course and prognosis of sarcoidosis in African-Americans versus Caucasians","volume":"17","author":"Reich","year":"2001","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.14-1120_bib20","first-page":"166","article-title":"Epidemiology, demographics, and genetics of sarcoidosis","volume":"13","author":"Rybicki","year":"1998","journal-title":"Semin Respir Infect"},{"issue":"3","key":"10.1378\/chest.14-1120_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0041-3879(69)90048-8","article-title":"Geographical variations in the incidence of sarcoidosis in Great Britain: a comparative study of four areas. A report to the Research Committee of the British Thoracic and Tuberculosis Association","volume":"50","year":"1969","journal-title":"Tubercle"},{"issue":"15","key":"10.1378\/chest.14-1120_bib22","first-page":"602","article-title":"Sarcoidosis in South Africa. A comparative study in whites, blacks and coloureds","volume":"52","author":"Benatar","year":"1977","journal-title":"S Afr Med J"},{"issue":"11","key":"10.1378\/chest.14-1120_bib23","first-page":"1179","article-title":"Sarcoidosis in the United States\u20141968 to 1984. Hospitalization and death","volume":"80","author":"Gillum","year":"1988","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1378\/chest.14-1120_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1753-0407.12090","article-title":"Glucocorticoid-induced hyperglycemia","volume":"6","author":"Perez","year":"2014","journal-title":"J Diabetes"},{"issue":"4","key":"10.1378\/chest.14-1120_bib26","first-page":"681","article-title":"Diabetes: an ignored complication of sarcoidosis","volume":"90","author":"Boruchowicz","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1378\/chest.14-1120_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1378\/chest.14-1120_bib28","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","article-title":"Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis","volume":"129","author":"Handa","year":"2006","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.14-1120_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000194667","article-title":"Pulmonary haemodynamics at rest and during exercise in patients with sarcoidosis","volume":"46","author":"G\u0142uskowski","year":"1984","journal-title":"Respiration"},{"issue":"5","key":"10.1378\/chest.14-1120_bib30","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.14-1120_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5588\/ijtld.12.0428","article-title":"Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function","volume":"17","author":"Maimon","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1378\/chest.14-1120_bib32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.14-1120_bib33","first-page":"139","article-title":"Ambrisentan for sarcoidosis associated pulmonary hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"8","key":"10.1378\/chest.14-1120_bib34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215301781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215301781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:56:50Z","timestamp":1762124210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215301781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0012369215301781"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-1120","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial Difference in Sarcoidosis Mortality in the United States","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.14-1120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}